Clene Inc.

Company Profile

Clene Inc. had its IPO on 2020-12-31 under the ticker symbol CLNN.

The company operates in the Healthcare sector and Biotechnology industry. Clene Inc. has a staff strength of 75 employees.

Stock update

Shares of Clene Inc. opened at $1.09 at the start of the last trading session i.e. 2023-06-02.

The stocks traded within a range of $0.99 - $1.09, and closed at $1.04.

This is a -0.95% slip from the previous day's closing price.

A total volume of 221,517 shares were traded at the close of the day’s session.

In the last one week, shares of Clene Inc. have increased by +8.33%.

Clene Inc.'s Key Ratios

Clene Inc. has a market cap of $79.57 million, indicating a price to book ratio of 108.1979 and a price to sales ratio of 187.0781.

In the last 12-months Clene Inc.’s revenue was $550000 with a gross profit of $447000 and an EBITDA of $-44579000. The EBITDA ratio measures Clene Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clene Inc.’s operating margin was -8328.18% while its return on assets stood at -61.4% with a return of equity of -14530.26%.

In Q1, Clene Inc.’s quarterly earnings growth was a positive 61.4% while revenue growth was a positive 256.7%.

Clene Inc.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.44 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clene Inc.’s profitability.

Clene Inc. stock is trading at a EV to sales ratio of 204.4827 and a EV to EBITDA ratio of -4.2737. Its price to sales ratio in the trailing 12-months stood at 187.0781.

Clene Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$39.89 million

Total Liabilities

$16.88 million

Operating Cash Flow

$4.72 million

Capital Expenditure

$278000

Dividend Payout Ratio

0%

Clene Inc. ended 2023 with $39.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $39.89 million while shareholder equity stood at $-1627000.00.

Clene Inc. ended 2023 with $0 in deferred long-term liabilities, $16.88 million in other current liabilities, 8000.00 in common stock, $-204989000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $18.44 million and cash and short-term investments were $18.44 million. The company’s total short-term debt was $10,335,000 while long-term debt stood at $16.62 million.

Clene Inc.’s total current assets stands at $24.82 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $3.11 million compared to accounts payable of $608000.00 and inventory worth $88000.00.

In 2023, Clene Inc.'s operating cash flow was $4.72 million while its capital expenditure stood at $278000.

Comparatively, Clene Inc. paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$1.04

52-Week High

$5.13

52-Week Low

$0.85

Analyst Target Price

$8.43

Clene Inc. stock is currently trading at $1.04 per share. It touched a 52-week high of $5.13 and a 52-week low of $5.13. Analysts tracking the stock have a 12-month average target price of $8.43.

Its 50-day moving average was $1.01 and 200-day moving average was $1.47 The short ratio stood at 15.84 indicating a short percent outstanding of 0%.

Around 6420% of the company’s stock are held by insiders while 413% are held by institutions.